Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2) Peptide
Quick Overview for Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2) Peptide (ABIN939776)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- KGFVNILMTS FLQYISSEVN PPSDETDSSS APSKEQLEQE KQLLLSFKPV
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of EIF4 G2 antibody,
Alternative Names: EIF4G2 control peptide, EIF4G2 antibody Blocking Peptide, Anti-EIF4G2 Blocking Peptide, Eukaryotic Translation Initiation Factor 4 Gamma 2 Blocking Peptide, EIF4G2, EIFG2-4, EIFG2 4, EIFG2-4 Blocking Peptide, EIFG2 4 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- EIF4G2 (Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))
-
Background
- Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. EIF4G2 shares similarity with the C-terminal region of eIF4G that contains the binding sites for eIF4A and eIF3, eIF4G, in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G, which supports cap-dependent and independent translation, EIF4G2 functions as a general repressor of translation by forming translationally inactive complexes.
-
Molecular Weight
- 39 kDa
Target
-